Literature DB >> 11590345

[Multiple skin and mouth squamous cell carcinomas related to long-term treatment with hydroxyurea].

E Estève1, V Georgescu, P Heitzmann, L Martin.   

Abstract

INTRODUCTION: Cutaneous side-effects of hydroxyurea treatment are frequently observed. Squamous cell carcinomas are the most severe among them. We report a patient with skin and mouth carcinomas after hydroxyurea treatment. To the best of our knowledge, this is the first case reported. OBSERVATION: A 83-year-old woman had been treated with hydroxyurea from 1985 to 1998 for polycythemia vera. She was referred to our institution in 1998 for painful erosions of both hands. Clinical examination revealed a squamous cell carcinoma leading to amputation of a finger. Hydroxyurea was stopped at this time, and the patient underwent treatment with pipobroman. From May 1998 to March 2000, the patient developed numerous skin keratoses and four squamous cell carcinomas on both hands. In September 2000 and October 2000, two additional skin carcinomas and two mouth carcinomas were diagnosed. DISCUSSION: Cutaneous carcinomas are severe side effects of hydroxyurea therapy. They usually occur after several years of treatment and their outcome may be lethal. The chronology and clinical signs are in favour of implicating hydroxyurea in the development of skin and mouth carcinomas. Despite a bibliographic research using Medline and Embase data bases, we could not find another case-report with simultaneous occurrence of skin and mouth carcinomas after hydroxyurea therapy. This observation emphasizes the need of a long term follow-up in patients receiving hydroxyurea.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590345

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  7 in total

Review 1.  Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia.

Authors:  David Dingli; Ayalew Tefferi
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

Review 2.  [Ulcers following therapy with hydroxyurea. Three case reports and review of the literature].

Authors:  S Boneberger; R A Rupec; T Ruzicka
Journal:  Hautarzt       Date:  2010-07       Impact factor: 0.751

3.  Shoutai pills improve the quality of oocytes exposed to the chemotherapeutic drug Hydroxyurea.

Authors:  Yuwei Zhang; Ruizhi Tan; Li Wang; Xiaoyan Shi; Yu Li; Xia Zhong; Xiaoxia He; Bo Xiong
Journal:  Aging (Albany NY)       Date:  2020-05-10       Impact factor: 5.682

Review 4.  MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives.

Authors:  Hans Carl Hasselbalch; Mads Emil Bjørn
Journal:  Mediators Inflamm       Date:  2015-10-28       Impact factor: 4.711

5.  Laser Photobiomodulation for a Complex Patient with Severe Hydroxyurea-Induced Oral Ulcerations.

Authors:  Marco Cabras; Adriana Cafaro; Alessio Gambino; Roberto Broccoletti; Ercole Romagnoli; Davide Marina; Paolo G Arduino
Journal:  Case Rep Dent       Date:  2016-11-10

6.  Sickle cell disease induces resistance to cutaneous carcinogenesis.

Authors:  Boutros Soutou; Patricia Senet; François Lionnet; Anoosha Habibi; Sélim Aractingi
Journal:  Orphanet J Rare Dis       Date:  2020-03-06       Impact factor: 4.123

Review 7.  Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses.

Authors:  Vibe Skov
Journal:  Cancers (Basel)       Date:  2020-08-06       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.